GW117: A novel serotonin (5-HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant-like activity in rodents

被引：10
|
作者：
Gao, Nana [1 ]
Zheng, Wei [2 ]
Murezati, Tiliwaerde [2 ]
Gu, Wei [3 ]
Li, Xiaorong [2 ]
Jin, Zengliang [2 ]
机构：
[1] Captial Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg & Clin Nutr, Beijing, Peoples R China
[2] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100069, Peoples R China
[3] Beijing Guangwei Pharmaceut Technol Co Ltd, Beijing, Peoples R China
来源：
CNS NEUROSCIENCE & THERAPEUTICS | 2021年 / 27卷 / 06期
基金：
中国国家自然科学基金;
关键词：
5‐ HT2C receptor; antidepressant; GW117; melatonin receptor; REUPTAKE INHIBITORS; AGOMELATINE; NOREPINEPHRINE; DRUGS; MODEL; DEPRESSION; STRESS; RATS;
D O I：
10.1111/cns.13630
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Aims To evaluate the antidepressant-like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [S-35]-GTP gamma S and [H-3]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant-like and anxiolytic-like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5-HT2C) receptor antagonist and melatonin type 1 and 2 (MT1/MT2) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.
引用
收藏
页码：702 / 713
页数：12
相关论文
共 50 条
  • [1] Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II)
    Ettaoussi, Mohamed
    Peres, Basile
    Errazani, Aicha
    Boutin, Jean A.
    Caignard, Daniel-Henri
    Delagrange, Philippe
    Melnyk, Patricia
    Berthelot, Pascal
    Yous, Said
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 : 822 - 833
  • [2] Synthesis and Pharmacological Evaluation of a series of the Agomelatine Analogues as Melatonin MT1/MT2 Agonist and 5-HT2C Antagonist
    Ettaoussi, Mohamed
    Sabaouni, Ahmed
    Peres, Basile
    Landagaray, Elodie
    Nosjean, Olivier
    Boutin, Jean A.
    Caignard, Daniel-Henri
    Delagrange, Philippe
    Berthelot, Pascal
    Yous, Said
    CHEMMEDCHEM, 2013, 8 (11) : 1830 - 1845
  • [3] Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
    Olie, Jean Pierre
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 661 - 673
  • [4] Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers
    Kamal, Maud
    Gbahou, Florence
    Guillaume, Jean-Luc
    Daulat, Avais M.
    Benleulmi-Chaachoua, Abla
    Luka, Marine
    Chen, Patty
    Anaraki, Dina Kalbasi
    Baroncini, Marc
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    Prevot, Vincent
    Delagrange, Philippe
    Jockers, Ralf
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (18) : 11537 - 11546
  • [5] Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)
    Tabeeva, G. R.
    Sergeev, A. V.
    Gromova, S. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (09) : 32 - 36
  • [6] Nociceptive responses in melatonin MT2 receptor knockout mice compared to MT1 and double MT1/MT2 receptor knockout mice
    Posa, Luca
    Lopez-Canul, Martha
    Rullo, Laura
    De Gregorio, Danilo
    Dominguez-Lopez, Sergio
    Kaba Aboud, Matthew
    Caputi, Francesca Felicia
    Candeletti, Sanzio
    Romualdi, Patrizia
    Gobbi, Gabriella
    JOURNAL OF PINEAL RESEARCH, 2020, 69 (03)
  • [7] A Cluster Headache Responsive to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist
    Imai, Noboru
    INTERNAL MEDICINE, 2016, 55 (17) : 2483 - 2485
  • [8] The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors
    Sumaya, IC
    Masana, MI
    Dubocovich, ML
    JOURNAL OF PINEAL RESEARCH, 2005, 39 (02) : 170 - 177
  • [9] Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models
    Rivara, S
    Lorenzi, S
    Mor, M
    Plazzi, PV
    Spadoni, G
    Bedini, A
    Tarzia, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (12) : 4049 - 4060
  • [10] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
    Rosenzweig-Lipson, Sharon
    Sabb, Annmarie
    Stack, Gary
    Mitchell, Paul
    Lucki, Irwin
    Malberg, Jessica E.
    Grauer, Steve
    Brennan, Julie
    Cryan, John F.
    Rizzo, Stacey J. Sukoff
    Dunlop, John
    Barrett, James E.
    Marquis, Karen L.
    PSYCHOPHARMACOLOGY, 2007, 192 (02) : 159 - 170
12345